foxo4-dri cancer For Sale (10mg) Peptide inhibitors targeting FOXO4-p53 interactions
Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI 10mg FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes PMC FOXO4 DRI: A Breakthrough Peptide Targeting Aging at Its Roots PARTICLE, s. r. o. foxo4 dri cancer Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cells Development of a novel senolytic
Pay in 4 interest-free payments of $5.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13





